Menu
12/04/2006
Breast cancer patient wins Herceptin court battle
A breast cancer patient has won an appeal to receive the drug Herceptin on the NHS.
Ann Marie Rogers, 54, from Swindon went to the Court of Appeal after the High Court ruled that Swindon Primary Care Trust had not acted unlawfully in refusing to give her the drug.
However, the Court of Appeal ruled that the PCT's policy in denying her the treatment was "irrational and unlawful".
Herceptin is currently only licensed for the treatment of advanced breast cancer, although research has suggested that it could also help those patients in the early stages of breast cancer, such as Ms Rogers.
Swindon PCT had refused to give Ms Rogers Herceptin because it was not licensed for the treatment of early-stage breast cancer and argued that this was in line with the government guidance.
Speaking to reporters after the ruling today, Ms Rogers said that she "couldn't have asked for a better verdict" and said she felt like she had "won the lottery".
Roche, the manufacturers of Herceptin, applied to European drug authorities for the drug to be used to treat early-stage breast cancer in February.
The National Institute for Health and Clinical Excellence promised to fast-track appraisal of Herceptin once the European authorities granted permission and if the drug proved to be cost effective.
A year's treatment of the drug costs around £20,000.
(KMcA)
Ann Marie Rogers, 54, from Swindon went to the Court of Appeal after the High Court ruled that Swindon Primary Care Trust had not acted unlawfully in refusing to give her the drug.
However, the Court of Appeal ruled that the PCT's policy in denying her the treatment was "irrational and unlawful".
Herceptin is currently only licensed for the treatment of advanced breast cancer, although research has suggested that it could also help those patients in the early stages of breast cancer, such as Ms Rogers.
Swindon PCT had refused to give Ms Rogers Herceptin because it was not licensed for the treatment of early-stage breast cancer and argued that this was in line with the government guidance.
Speaking to reporters after the ruling today, Ms Rogers said that she "couldn't have asked for a better verdict" and said she felt like she had "won the lottery".
Roche, the manufacturers of Herceptin, applied to European drug authorities for the drug to be used to treat early-stage breast cancer in February.
The National Institute for Health and Clinical Excellence promised to fast-track appraisal of Herceptin once the European authorities granted permission and if the drug proved to be cost effective.
A year's treatment of the drug costs around £20,000.
(KMcA)
Related UK National News Stories
Click here for the latest headlines.
09 June 2006
Herceptin approved for early breast cancer use on NHS
Breast cancer drug Herceptin has been approved for the treatment of early stage breast cancer on the NHS by the National Institute for Health and Clinical Excellence. Herceptin is effective on the HER2 positive form of breast cancer, which forms around 20% of all breast cancer cases.
Herceptin approved for early breast cancer use on NHS
Breast cancer drug Herceptin has been approved for the treatment of early stage breast cancer on the NHS by the National Institute for Health and Clinical Excellence. Herceptin is effective on the HER2 positive form of breast cancer, which forms around 20% of all breast cancer cases.
24 May 2006
Herceptin granted UK license
Breast cancer drug Herceptin has been licensed for use in the early stages of the disease in the UK by the European Medicines Agency. The drug, which is already used in Britain to treat the later stages of breast cancer, will now be appraised by the National Institute of Health and Clinical Excellence to see if it is safe and cost-effective.
Herceptin granted UK license
Breast cancer drug Herceptin has been licensed for use in the early stages of the disease in the UK by the European Medicines Agency. The drug, which is already used in Britain to treat the later stages of breast cancer, will now be appraised by the National Institute of Health and Clinical Excellence to see if it is safe and cost-effective.
27 June 2014
Blood Test Could Predict Breast Cancer - Research
A blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, according to research by the University College London (UCL).
Blood Test Could Predict Breast Cancer - Research
A blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, according to research by the University College London (UCL).
05 October 2005
Breast cancer drug to be fast-tracked
Health Secretary Patricia Hewitt has announced that all breast cancer sufferers will have the opportunity to be treated with the drug, Herceptin.
Breast cancer drug to be fast-tracked
Health Secretary Patricia Hewitt has announced that all breast cancer sufferers will have the opportunity to be treated with the drug, Herceptin.
07 February 2006
Breast cancer sufferer faces wait on drug ruling
A breast cancer sufferer will have to wait to learn the result of her legal battle against the NHS' decision not to provide her with the drug, Herceptin. Ann Marie Rogers, 54, from Swindon, launched her case after being refused the drug, which is only licensed for the treatment of advanced breast cancer, by Swindon Primary Care Trust.
Breast cancer sufferer faces wait on drug ruling
A breast cancer sufferer will have to wait to learn the result of her legal battle against the NHS' decision not to provide her with the drug, Herceptin. Ann Marie Rogers, 54, from Swindon, launched her case after being refused the drug, which is only licensed for the treatment of advanced breast cancer, by Swindon Primary Care Trust.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
